Your browser does not support iframes.
As a leading global manufacturer of medicines and health solutions, Teva embraces a global collaborative focus on developing solutions to the issue of antimicrobial resistance (AMR), and commits to working with industry peers and global health organizations to identify solutions that will help protect people and provide new ways to reduce AMR.
Following discussions at the World Economic forum in Davos, Switzerland in 2016, the global pharmaceutical industry and health organizations came together to commit to collective action. Teva was proud to be among members of the life sciences industry who joined the resulting AMR Industry Alliance, committed to finding solutions to this issue together.
As a partner to the industry, health associations and regulators in finding solutions to AMR, we commit to:
Through these actions, we aim to be active partners in the fight against AMR and to enable millions of people live healthier, better days.
Learn more about AMR on the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) website
Learn more about the AMR Industry Alliance